Immunohistochemical analysis of these markers in primary tumors demonstrated a significant correlation between the EMT molecular phenotype (increased p-Src, decreased E-cadherin, and vimentin expression) and aggressive tumor features including penetrating invasive fronts, high-grade sarcomatoid transformation, and lymph node metastasis. This evidence concerns the gene CDH1 and neoplasm.